Lenalidomide/Rituximab/Tafasitamab Regimen

Preferred Label : Lenalidomide/Rituximab/Tafasitamab Regimen;

NCIt synonyms : Tafasitamab/Lenalidomide/Rituximab; Lenalidomide/Rituximab/Tafasitamab-cxix; Lenalidomide/Tafasitamab/Rituximab; Lenalidomide-Rituximab-Tafasitamab; Revlimid/Rituxan/Monjuvi; Tafasitamab/Rituximab/Lenalidomide; Rituximab/Tafasitamab-cxix/Lenalidomide;

NCIt definition : A regimen consisting of lenalidomide, rituximab, and tafasitamab that can be used for the treatment of classic follicular lymphoma.;

Détails

Origin ID

C215163;

chemotherapy_regimen_has_component
- Lenalidomide [NCIt concept]
- Rituximab [NCIt concept]
- Tafasitamab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients